Stock Movers

iHeartPodcasts
undefined
Sep 17, 2025 • 4min

StubHub Falls, Workday Rises, Hologic Soars

StubHub's IPO stumbled, with shares dropping 6.4% after raising $800 million. In contrast, Workday's stocks surged up to 10% thanks to a massive $2 billion investment from Elliott Investment Management and exciting acquisition news. Meanwhile, Hologic's shares soared amid renewed interest from Blackstone and TPG for a potential acquisition. The business landscape is buzzing with these significant moves!
undefined
Sep 17, 2025 • 8min

Closing Bell: Workday Climbs, Krispy Kreme Rallies, Cracker Barrel Sinks

Workday's stock surged after a major investment from Elliott Management, highlighting recent achievements in growth and customer retention. The company also announced a $1.1 billion AI acquisition and new partnerships. Krispy Kreme saw a bounce in shares following FBI Director Kash Patel's favorable comments during congressional testimony about his stock purchases. Other notable discussions included a Lyft and Waymo partnership and Cracker Barrel's disappointing guidance, creating a whirlwind of market movements.
undefined
6 snips
Sep 17, 2025 • 6min

Workday Higher, Lyft Rises, Nvidia Down on China's Orders to Stop Buying Their Chips

Workday's shares climb as Elliott Investment Management praises its impressive progress and strategic enhancements. Meanwhile, Lyft's partnership with Waymo signals an exciting future for robotaxi services in Nashville, poised to rival Uber. On a down note, Nvidia faces a stock drop after China halts orders for its AI chips, leaving CEO Jensen Huang expressing disappointment and patience. The podcast also touches on the impending IPO of StubHub, highlighting its market challenges and pricing concerns.
undefined
Sep 17, 2025 • 4min

Nvidia Down, General Mills Lower, Eli Lilly Up on GLP-1 Pill Performance

Nvidia's shares tumble as China's internet regulator halts purchases of their AI chips, disappointing the CEO. General Mills sees a drop in North American sales despite beating EPS expectations, as consumers cook at home amid inflation. In contrast, Eli Lilly's new oral GLP-1 diabetes drug shows impressive results, outperforming its competitor in weight loss and blood sugar control. Doctors are optimistic about its potential to make diabetes treatment more accessible and affordable.
undefined
Sep 17, 2025 • 4min

Nvidia China Ban; New Fortress Soars; Workday Upgrade

Nvidia faces setbacks as China's internet regulator halts orders for its RTX Pro 6000D, sparking market concern. Meanwhile, New Fortress Energy is on the rise, buoyed by a lucrative $4 billion liquefied natural gas deal with Puerto Rico. Workday enjoys a boost following analyst upgrades and a comprehensive review of its strategic improvements. The podcast delves into how these developments reflect the ever-shifting landscape of stock market dynamics.
undefined
Sep 17, 2025 • 5min

Nvidia China Ban; Baidu Jumps; Eli Lilly Lower

Nvidia faces a stock price drop after China orders a halt to its RTX Pro 6000D chip sales. Meanwhile, optimism surges for Baidu as its stock jumps 40% thanks to potential in AI chips, surpassing the struggles of its online ads. In the pharmaceutical sector, Eli Lilly's shares fall amid Novo Nordisk's strategy to personalize obesity treatment, affecting market dynamics. The contrasting fortunes of these companies reflect the shifting landscape in tech and healthcare.
undefined
Sep 17, 2025 • 4min

Novo Nordisk Rises, Centrica Gains, Inditex Up

The podcast dives into exciting stock movements, starting with Novo Nordisk, which received a buy upgrade, becoming the top pick in the obesity sector. Centrica also gets a boost with an overweight rating, indicating strong potential from upcoming projects. Meanwhile, Inditex stands out as UBS raises its rating to buy, thanks to a strong start to the autumn-winter fashion season. These strategic upgrades suggest promising growth trajectories for these companies in a competitive market.
undefined
Sep 16, 2025 • 6min

Hershey Rises, Hims & Hers Drops, Warner Bros. Discovery Falls

Hershey's stock surged after analyst upgrades highlighted improving market trends and strong pricing power, paving the way for potential growth. Hims & Hers faced a setback as the FDA issued a warning over misleading health claims, causing shares to drop. Meanwhile, Warner Bros. Discovery plummeted following a downgrade amid shaky merger rumors with Paramount, raising concerns about media consolidation and regulatory scrutiny. The episode digs into the complexities of stock market fluctuations and investment strategies.
undefined
8 snips
Sep 16, 2025 • 7min

Closing Bell: Oracle Pops on TikTok News, Ralph Lauren Falls, The New York Times Stock Down

Oracle's stock soared as news broke of a potential acquisition of TikTok's US operations, with high-profile investors backing the move for a safer social media platform. Meanwhile, Ralph Lauren's shares tumbled as the company projected stagnant revenue growth. The New York Times faced stock declines, grappling with significant legal challenges. The episode also delves into interest rate predictions and their implications for investments, along with fluctuating stocks in the tech and pharma sectors, including Moderna and Tesla.
undefined
Sep 16, 2025 • 3min

Oracle Climbs, United Airlines Down

Oracle's shares are on the rise thanks to promising developments in TikTok negotiations, which could reshape its U.S. operations. The potential collaboration with a consortium of investors shines a light on the delicate U.S.-China tech relationship. Meanwhile, United Airlines faces a downturn, but its CEO suggests that increasing travel demand points to an economic rebound. The airline industry serves as a real-time barometer for national economic health, giving investors a glimmer of hope amidst challenges.

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app